TMC Life Sciences BhdXKLS:0101 62 Gross Margin % is 64.65% as of Mar. 2026, which is 5% below its 10-year median of 67.85. GuruFocus rates XKLS:0101 with a GF Score™ of 62/100 and a GF Value™ of RM0.62 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 630 Healthcare Providers & Services companies, TMC Life Sciences Bhd ranks better than 72.38% on this metric.
XKLS:0101's Gross Margin % is ranked better than 72.38% of 630
companies
in the Healthcare Providers & Services industry
Industry Median: 40.075
vs XKLS:0101: 63.48
TMC Life Sciences Bhd had a gross margin of 64.65% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for TMC Life Sciences Bhd was -0.40% per year.
TMC Life Sciences Bhd (XKLS:0101) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
TMC Life Sciences Bhd had a gross margin of 64.65% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
TMC Life Sciences Bhd Gross Margin % Related Terms
TMC Life Sciences Bhd Gross Margin % Historical Data
* Premium members only.
The historical data trend for TMC Life Sciences Bhd's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0101 vs HCA, THC, DVA: Gross Margin % Comparison
For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TMC Life Sciences Bhd Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's Gross Margin % distribution charts can be found below:
* The bar in red indicates where TMC Life Sciences Bhd's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
TMC Life Sciences Bhd (XKLS:0101) has a Gross Margin % of 64.65% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on TMC Life Sciences Bhd and its competitors. This is near median its historical median of 67.85. Over the past decade, TMC Life Sciences Bhd's Gross Margin % has ranged from 63.48 to 71.07. According to the industry distribution chart, TMC Life Sciences Bhd ranks #174 out of 630 companies in the Healthcare Providers & Services industry, placing it in the top 27.6%.
Is TMC Life Sciences Bhd's Gross Margin % too high?
TMC Life Sciences Bhd's current Gross Margin % of 64.65% is near median its 10-year median of 67.85. Over the past 10 years, this metric has ranged from a low of 63.48 to a high of 71.07. The Healthcare Providers & Services industry median Gross Margin % is 40.08. TMC Life Sciences Bhd's value of 64.65% is 61.3% above this industry median. Based on the distribution chart, TMC Life Sciences Bhd ranks #174 out of 630 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, TMC Life Sciences Bhd has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TMC Life Sciences Bhd's Gross Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, TMC Life Sciences Bhd ranks #174 out of 630 companies for Gross Margin %. This puts TMC Life Sciences Bhd in the upper half of its industry. The industry median Gross Margin % is 40.08. TMC Life Sciences Bhd's value of 64.65% is 61.3% above this benchmark. Historically, TMC Life Sciences Bhd's own Gross Margin % has ranged from 63.48 to 71.07 over the past decade. While the company's 10-year median is 67.85 vs. the industry median of 40.08, TMC Life Sciences Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.08, based on 630 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TMC Life Sciences Bhd's current Gross Margin % of 64.65% is 61.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on TMC Life Sciences Bhd and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TMC Life Sciences Bhd's current Gross Margin % is 64.65%, which is near median its own 10-year median of 67.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMC Life Sciences Bhd stock overvalued right now?
Based on GuruFocus' analysis, TMC Life Sciences Bhd (XKLS:0101) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.62, compared to a current price of RM0.45 — trading 27.4% below its estimated fair value. The current Gross Margin % is 64.65%, which is near median its 10-year median of 67.85 and 61.3% above the Healthcare Providers & Services industry median of 40.08. TMC Life Sciences Bhd's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For TMC Life Sciences Bhd (XKLS:0101), the current Gross Margin % is 64.65% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TMC Life Sciences Bhd (XKLS:0101) Overvalued in 2026?
Based on GuruFocus' analysis, TMC Life Sciences Bhd stock appears to be undervalued.
The current stock price of RM0.45 is trading 27.4% below its estimated GF Value™ of RM0.62.
GuruFocus considers TMC Life Sciences Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0101:
Gross Margin %: 64.65% (near median its 10-year median of 67.85)
GF Value™: RM0.62 vs. price of RM0.45 (27.4% below fair value)
Industry Position: 61.3% above the Healthcare Providers & Services median (#174 of 630)
No single metric tells the full story. See the XKLS:0101 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
62GF Score
Get the complete analysis for XKLS:0101
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0101 has been successfully added to your 
